Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 12/23/2022
Closing price: 84.75
Support price level: | $73.03 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 33.1 |
Beta | 0.38 |
- The price of this low-beta stock is expected to increase by 0.38% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- GILD is above its 200-day moving average, providing a measure of support for long positions.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$57.72 | $89.47 | 87.6% |
200 day | 50 day | 20 day | 10 day |
$67.05 | $81.28 | $87.12 | $86.55 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
26.0% | 30.9% | 22.8% | 23.9% |
- 6.2% in the next week.
- 13.5% in the next month.
- 42.7% in the next year.
Company news for Gilead Sciences Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks